СЕРДЕЧНАЯ НЕДОСТАТОЧНОСТЬ, САХАРНЫЙ ДИАБЕТ, БЕТА-БЛОКАТОРЫ И РИСК ГИПОГЛИКЕМИЙ
Andrei A. Aleksandrov, Svetlana Semenovna Kukharenko, Е Н Дроздова et al. · 2008
Cited by 0 works.
Authors
- Svetlana Semenovna Kukharenko
- Е Н Дроздова
- I. Z. Bondarenko
- N. D. Tabidze
- Marina Vladimirovna Shestakova
References
- β-Blockers and Sudden Cardiac Death
- Metabolic effects of carvedilol vs. metoprolol in patients with type 2 diabetes mellitus and hypertension: A randomized controlled trial
- Regulation of cardiac vulnerability by the cerebral defense system
- Central beta-adrenergic mechanisms may modulate ischemic ventricular fibrillation in pigs.
- Incidence of sudden cardiac death associated with coronary artery occlusion in dogs with hypertension and left ventricular hypertrophy is reduced by chronic beta-adrenergic blockade.
- Cardiac vagal activity: a target for intervention in heart disease
- Systemic and Local Adrenergic Regulation of Muscle Glucose Utilization During Hypoglycemia in Healthy Subjects
- β‐Blocker use and diabetes symptom score: results from the GEMINI study
- Prevention of ventricular fibrillation requires central β-adrenoceptor blockade in rabbits